ArticleScientific reports2025

Long-term survival outcomes of neoadjuvant chemotherapy in stage II-III HR+/HER2- breast cancer.

Jiaxing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.